WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ocular Therapeutix revenue was $63.72M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $17.1M, up 10.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OCUL annual revenue was $63.7M, with 9% growth year-over-year.

OCUL past revenue growth

How has OCUL's revenue growth performed historically?

Company
9.03%
Industry
497.69%
Market
20.68%
OCUL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OCUL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OCUL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OCUL revenue history

Current Revenue
$63.7M
Current Earnings
-$193.5M
Current Profit Margin
-303.7%

Be the first to know when OCUL announces revenue.

OCUL Revenue History By Year

OCUL Yearly RevenueOCUL RevenueOCUL ChangeOCUL Revenue Growth
2024-12-31$63.72M$5.28M+9.03%
2023-12-31$58.44M$6.95M+13.49%
2022-12-31$51.49M$7.97M+18.32%
2021-12-31$43.52M$26.12M+150.08%
2020-12-31$17.40M$13.18M+311.71%
2019-12-31$4.23M$2.24M+112.41%
2018-12-31$1.99M$67.00k+3.48%
2017-12-31$1.92M$36.00k+1.91%
2016-12-31$1.89M$137.00k+7.83%
2015-12-31$1.75M$978.00k+126.68%
2014-12-31$772.00kN/AN/A
2013-12-31$0.00-$10.00k-100.00%
2012-12-31$10.00kN/AN/A

1 of 1

Ocular Therapeutix Revenue FAQ

What was OCUL's revenue last quarter?

On Invalid Date, Ocular Therapeutix (NASDAQ: OCUL) reported Q4 2024 revenue of $17.08 million up 15.41% year over year. In the same quarter last year, Ocular Therapeutix's revenue was $14.80 million.

What was Ocular Therapeutix's revenue in 2024?

Ocular Therapeutix's annual revenue for the twelve months ending Dec 31, 2024 was $63.72 million, a 9.03% increase year over year.

How much does Ocular Therapeutix make in a day?

Based on Ocular Therapeutix annual revenue for the past five years, OCUL makes an average of $128,539.73 per day.

What was Ocular Therapeutix's annual revenue growth in the past year?

As of Q2 2025, Ocular Therapeutix's revenue has grown 9.03% year over year. This is 488.66 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Ocular Therapeutix's revenue in the past year totaled $63.72 million.

How much does Ocular Therapeutix make in a year?

Ocular Therapeutix's revenue by year for the past five years is:
  • Ocular Therapeutix's revenue for the twelve months ending Dec 31, 2024 was $63.72 million, a 9.03% increase year over year.
  • Ocular Therapeutix's annual revenue for Dec 31, 2023 was $58.44 million, a 13.49% increase from 2022.
  • Ocular Therapeutix's annual revenue for 2022 was $51.49 million, a 18.32% increase from 2021.
  • Ocular Therapeutix's annual revenue for 2021 was $43.52 million, a 150.08% increase from 2020.
  • Ocular Therapeutix's annual revenue for 2020 was $17.40 million, a 311.71% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.